WASHINGTON – Senate Finance Committee Chairman Chuck
Grassley (R-Iowa) and Sen. Dick Durbin (D-Ill.) released the following statements
regarding a federal judge’s ruling that direct-to-consumer (DTC) prescription
drug advertisements do not have to include the list price of the drug.
“The ever-rising cost of prescription drugs is one of the
most pressing problems in our health care system. Targeted, bipartisan
solutions will provide real relief to patients and health care consumers. The
direct-to-consumer price disclosure measure is a commonsense approach that will
help reduce drug costs,” Grassley said. “There is a severe lack of
transparency in the health care system. The DTC measure would shine a light on
the outrageous cost of medications and give health care consumers information
they need to make the best decision for their circumstance. Senator Durbin and I plan on renewing our push to provide a legislative
solution to this problem by moving our bipartisan bill introduced earlier this
year that would require this type of disclosure by federal law.”
“Apparently a
little daylight is too much for Big Pharma. Rather than level with the American
public about the sky-high cost of their drugs—when they run their non-stop
ads—Pharma sued to block patients from knowing the price. A federal court agreed
with Pharma this week, but this isn’t over. I believe Congress should
step up and pass a law to require price disclosure. I look forward to
continuing to work with Chairman Grassley for swift passage of our bipartisan
bill to provide patients with the information about drug prices they deserve,” Durbin said.
The average American sees
nine DTC prescription drug ads each day. Studies show that patients are more
likely to ask their doctor for a specific brand-name medication, and doctors
are more likely to prescribe one, when they have been marketed directly with
drug advertisement.
Grassley and Durbin introduced
the bipartisan measure to require price disclosures in DTC ads. The senators
also offered
an amendment in May of this year to codify the rule after court interference.
The measure passed the Senate but was ultimately removed from the
Defense-Labor-HHS-Education appropriations “minibus” package.
Earlier this year, the Department of Health and Human
Services (HHS) ruled that pharmaceutical companies would be required to include
list prices of their prescription drugs in DTC ads.
The
legislation has been endorsed by AARP, American Medical Association, American
Hospital Association and Campaign for Sustainable Rx Pricing.
-30-